Healthcare · Pharmaceuticals & Biotechnology
The largest companies in the same industry by market cap. This company ranks #3 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.
| Company | Market cap (₹ Cr) | PE (TTM) | ROE | 1Y return | Div. yield | Quality | Valuation | Momentum |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 427,010 | 143.5 | 13.7% | 7.6% | — | 72 | 8 | 30 |
| Divi's Laboratories Limited | 244,125 | 83.0 | 15.3% | 57.8% | 0.33% | 70 | 4 | 51 |
| Torrent Pharmaceuticals Limited (this stock) | 161,506 | 77.7 | 12.2% | 35.3% | 0.80% | 56 | 0 | 31 |
| Zydus Lifesciences Limited | 113,616 | 32.6 | 17.3% | 14.5% | 0.09% | 74 | 24 | 84 |
| Cipla Limited | 107,888 | 35.1 | 11.2% | -11.7% | 0.97% | 73 | 29 | 62 |
| Laurus Labs Limited | 106,505 | 122.0 | 17.1% | 128.4% | — | 78 | 24 | 53 |
| Mankind Pharma Limited | 102,382 | 46.9 | 11.7% | 0.9% | — | 68 | 12 | 86 |
| Dr. Reddy's Laboratories Limited | 100,411 | 150.9 | 10.9% | -3.7% | — | 62 | 33 | 71 |
| Period end | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) | Basic EPS |
|---|---|---|---|---|
| June 30, 2026 | 4,921 | 733 | 566 | ₹ |
| March 31, 2026 | 4,197 | 529 | 364 | ₹ |
| Dec. 31, 2025 | 3,303 | 814 | 635 | ₹ |
| Sept. 30, 2025 | 3,302 | 791 | 591 | ₹ |
| June 30, 2025 | 3,178 | 738 | 548 | ₹ |
| March 31, 2025 | 2,959 | 665 | 498 | ₹ |
| Dec. 31, 2024 | 2,809 | 691 | 503 | ₹ |
| Sept. 30, 2024 | 2,889 | 661 | 453 | ₹ |
| June 30, 2024 | 2,859 | 656 | 457 | ₹ |
| March 31, 2024 | 2,745 | 631 | 449 | ₹ |
| Dec. 31, 2023 | 2,732 | 631 | 443 | ₹ |
| Sept. 30, 2023 | 2,660 | 559 | 386 | ₹ |
| June 30, 2023 | 2,591 | 531 | 378 | ₹ |
The detailed income statement is standalone-only: the consolidated feed carries just revenue, PBT and net profit.
| Year ended | Revenue (₹ Cr) | PBT (₹ Cr) | Net profit (₹ Cr) |
|---|---|---|---|
| March 31, 2026 | 13,980 | 2,872 | 2,138 |
| March 31, 2025 | 11,516 | 2,673 | 1,911 |
| March 31, 2024 | 10,728 | 2,352 | 1,656 |
| March 31, 2023 | 9,620 | 1,847 | 1,245 |
Data unavailable.
| Year ended | Operating (₹ Cr) | Investing (₹ Cr) | Financing (₹ Cr) | Capex (₹ Cr) | Free Cash Flow (₹ Cr) |
|---|---|---|---|---|---|
| March 31, 2026 | 3,023 | -12,713 | 10,151 | 677 | 2,346 |
| March 31, 2025 | 2,585 | -540 | -2,298 | 611 | 1,974 |
| March 31, 2024 | 3,266 | -168 | -2,779 | 433 | 2,833 |
| March 31, 2023 | 2,368 | -2,356 | 77 | 574 | 1,794 |
| March 31, 2022 | 1,803 | -198 | -1,781 | 203 | 1,600 |
| Year ended | Total Assets (₹ Cr) | Total Equity (₹ Cr) | Reserves (₹ Cr) | Borrowings, Current (₹ Cr) | Borrowings, Non-current (₹ Cr) | Current Assets (₹ Cr) | Current Liabilities (₹ Cr) | Cash & Equivalents (₹ Cr) | Net Block (₹ Cr) | Inventory (₹ Cr) |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | 44,312 | 17,585 | 8,220 | 3,147 | 11,651 | 9,392 | 8,343 | 1,117 | 4,909 | 3,138 |
| March 31, 2025 | 14,990 | 7,591 | 7,422 | 1,834 | 1,192 | 5,623 | 4,717 | 573 | 3,455 | 2,541 |
| March 31, 2024 | — | — | — | — | — | — | — | — | — | — |
| March 31, 2023 | — | — | — | — | — | — | — | — | — | — |
| March 31, 2022 | — | — | — | — | — | — | — | — | — | — |
